Does BROLUCIZUMAB-DBLL Cause Retinal vasculitis? 323 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 323 reports of Retinal vasculitis have been filed in association with BROLUCIZUMAB-DBLL. This represents 11.5% of all adverse event reports for BROLUCIZUMAB-DBLL.
323
Reports of Retinal vasculitis with BROLUCIZUMAB-DBLL
11.5%
of all BROLUCIZUMAB-DBLL reports
3
Deaths
22
Hospitalizations
How Dangerous Is Retinal vasculitis From BROLUCIZUMAB-DBLL?
Of the 323 reports, 3 (0.9%) resulted in death, 22 (6.8%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Retinal vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 323 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
Anterior chamber cell (199)
What Other Drugs Cause Retinal vasculitis?
VANCOMYCIN (200)
AFLIBERCEPT (80)
BROLUCIZUMAB (52)
RANIBIZUMAB (52)
MYCOPHENOLATE MOFETIL (47)
METHOTREXATE (43)
PEGCETACOPLAN (40)
PREDNISONE (33)
PREDNISOLONE (29)
FARICIMAB\FARICIMAB-SVOA (26)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Retinal vasculitis Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM